Dose-dependent Hemodynamic Effect of Digoxin Therapy in Severe Verapamil Toxicity

Academic Emergency Medicine

Volumn 11, Issue 3, 2004, Pages 221-227

  Bania, Theodore C ^a,c   Chu, Jason ^a   Almond, Gregory ^b   Perez, Eric ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b METROPOLITAN HOSPITAL CENTER   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Digoxin; Toxicity; Verapamil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHLORIDE; DIGOXIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEATH; DIASTOLIC BLOOD PRESSURE; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INTOXICATION; DRUG MEGADOSE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE RELAXATION; HEART OUTPUT; HEMODYNAMICS; LINEAR REGRESSION ANALYSIS; LUNG ARTERY PRESSURE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TITRIMETRY;

EID: 1642311405     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2003.10.019     Document Type: Article

References (13)

1. Smilkstein ML. Making sense of verapamil overdose [editorial]. Ann Emerg Med. 1996; 3:99-100.
2. DeRoos F. Calcium channel blockers. In: Goldfrank L, Flomenbaum N, Lewin N, Weisman R, Howland M, Hoffman R (eds). Goldfrank's Toxicologic Emergencies. New York: McGraw-Hill, 2002.
3. Bania TC, Blaufeux B, Hughes S, Almond G, Homel P. Calcium and digoxin vs calcium alone for severe verapamil toxicity. Acad Emerg Med. 2000; 7:1089-96.
4. Ramos M, Grupp I, Pesola M, et al. Cardiac glycosides in the treatment of experimental overdose with calcium-blocking agents. Res Exp Med. 1992; 192:335-43.
5. Kline J, Tomazzewski C, Schroeder D, Raymond R. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine. J Pharmacol Exp Ther. 1993; 267:744-9.
6. Ettinger S, Suter P (eds). Digitalis and the cardiac glycosides. In: Canine Cardiology. Philadelphia: WB Saunders, 1970.
7. Braunwald E. Mechanism of action of calcium channel-blocking agents. N Engl J Med. 1982; 307:1618-27.
8. Triggle D. Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist. Am J Cardiol. 1996; 78(supp1 9A):7-12.
9. Smith T. Digitalis. N Engl J Med. 1988; 318:358-65.
10. Nola G. Assessment of the synergistic relationship between serum calcium and digitalis. Am Heart J. 1970; 79:499-507.
11. Caprio A, Farah A. The effect of the ionic milieu on the response of rabbit cardiac muscle to ouabain. J Pharmacol Exp Ther. 1967; 155:403-14.
12. Foster P, King R, Nicoll AB, Sipes D. Suppression of ouabain-induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents. Circulation. 1976; 53:315-21.
13. ++ channel blockers. J Pharmacol Exp Ther. 1986; 239:206-10.